| Literature DB >> 29770623 |
Thanita Wetcho1, Athithan Rattanaburi2, Kanet Kanjanapradit3.
Abstract
OBJECTIVE: To compare the quality of tissue from punch biopsy forceps (PB group) with round loop electrode (LE group) in colposcopically directed biopsy along with the evaluation of pain associated with each procedure.Entities:
Keywords: Biopsy; Cervix Uteri; Colposcopy; Diagnostic Equipment; Histology; Pain
Mesh:
Year: 2018 PMID: 29770623 PMCID: PMC5981104 DOI: 10.3802/jgo.2018.29.e52
Source DB: PubMed Journal: J Gynecol Oncol ISSN: 2005-0380 Impact factor: 4.401
Fig. 1Diagnostic equipment for cervical biopsy: Kevorkian biopsy forceps (upper) and the round loop electrode (lower).
Quality of tissue scores
| Quality of tissue | Scores (points) | ||
|---|---|---|---|
| 1 | 2 | 3 | |
| 1. Size of tissue | Tissue area is less than 5 mm2. | Tissue area is between 5–10 mm2. | Tissue area is more than 10 mm2. |
| 2. Site of tissue | There is neither epithelial nor stromal tissue. | There is either epithelial or stromal tissue. | There are both epithelial and stromal tissue. |
| 3. Tissue damage | There is either distortion or electrocautery effect that cannot evaluate pathologic result. | There is either distortion or electrocautery effect but can evaluate pathologic result. | There is neither distortion nor electrocautery effect. |
Fig. 2Flow of patients through the study.
LE group, round loop electrode group; PB group, punch biopsy forceps group.
Patient characteristics
| Characteristics | PB group (n=48) | LE group (n=48) | p-value | |
|---|---|---|---|---|
| Age (yr) | 38.9 (10.2) | 44.8 (12.2) | 0.011* | |
| Reproductive status | 0.190† | |||
| Premenopause | 42 (87.5) | 36 (75) | ||
| Menopause | 6 (12.5) | 12 (25) | ||
| Parity | 0.350† | |||
| Nulliparous | 15 (31.2) | 10 (20.8) | ||
| Multiparous | 33 (68.8) | 38 (79.2) | ||
| History of pills used | 0.520† | |||
| Yes | 15 (31.2) | 19 (39.6) | ||
| No | 33 (68.8) | 29 (60.4) | ||
| History of chronic pelvic pain/dysmenorrhea | 1.000† | |||
| Yes | 21 (43.8) | 21 (43.8) | ||
| No | 27 (56.2) | 27 (56.2) | ||
| Previous sexually transmitted disease | 0.490‡ | |||
| Yes | 3 (6.2) | 6 (12.5) | ||
| No | 45 (93.8) | 42 (87.5) | ||
| Smoking | 1.000‡ | |||
| Yes | 1 (2.1) | 0 (0) | ||
| No | 47 (97.9) | 48 (100) | ||
| Cytology report | 0.720† | |||
| ASC-US | 17 (35.4) | 15 (31.2) | ||
| ASC-H | 9 (18.8) | 8 (16.7) | ||
| LSIL | 17 (35.4) | 16 (33.3) | ||
| HSIL | 5 (10.4) | 9 (18.8) | ||
| HPV status | 0.740† | |||
| Unknown | 26 (54.2) | 27 (56.2) | ||
| HPV 16 or 18 positive | 14 (29.2) | 11 (22.9) | ||
| HPV 16 and 18 negative | 8 (16.7) | 10 (20.8) | ||
| Colposcopic assessment | 0.240† | |||
| Adequate | 39 (81.2) | 33 (68.8) | ||
| Inadequate | 9 (18.8) | 15 (31.2) | ||
| Reid colposcopic index score | 0.790† | |||
| 0–2 | 6 (12.5) | 8 (16.7) | ||
| 3–5 | 33 (68.8) | 30 (62.5) | ||
| 6–8 | 9 (18.8) | 10 (20.8) | ||
| Histological report | 0.730‡ | |||
| No dysplasia, koilocytosis | 30 (62.5) | 28 (58.3) | ||
| CIN1 | 6 (12.5) | 4 (8.3) | ||
| CIN2 | 1 (2.1) | 3 (6.2) | ||
| CIN3/CIS | 11 (22.9) | 13 (27.1) | ||
| Post-operative complication | 1.000‡ | |||
| Yes | 1 (2.1) | 1 (2.1) | ||
| No | 47 (97.9) | 47 (97.9) | ||
| Further management | 0.250† | |||
| Yes | 12 (25) | 16 (33.3) | ||
| No | 36 (75) | 32 (66.7) | ||
Values are presented as mean (SD) or number (%).
ASC-H, atypical squamous cells cannot rule out high-grade squamous intraepithelial lesion; ASC-US, atypical squamous cells of undetermined significance; CIN, cervical intraepithelial neoplasia; CIS, carcinoma in situ; HPV, human papillomavirus; HSIL, high-grade-squamous intraepithelial lesion; LE group, round loop electrode group; LSIL, low-grade squamous intraepithelial lesion; PB group, punch biopsy forceps group; SD, standard deviation.
*Student's t-test; †χ2 test; ‡Fisher's exact test.
Comparison of tissue scores
| Characteristics | PB group (n=48) | LE group (n=48) | p-value | |
|---|---|---|---|---|
| Total tissue scores (median) | 7 | 8 | 0.014* | |
| Size of tissue | <0.001† | |||
| 1 | 20 (41.7) | 5 (10.4) | ||
| 2 | 16 (33.3) | 17 (35.4) | ||
| 3 | 12 (25) | 26 (54.2) | ||
| Site of tissue | 0.240‡ | |||
| 1 | 0 (0) | 0 (0) | ||
| 2 | 3 (6.2) | 0 (0) | ||
| 3 | 45 (93.8) | 48 (100) | ||
| Tissue damage | 0.003† | |||
| 1 | 0 (0) | 0 (0) | ||
| 2 | 36 (75) | 47 (97.9) | ||
| 3 | 12 (25) | 1 (2.1) | ||
Values are presented as number (%).
LE group, round loop electrode group; PB group, punch biopsy forceps group.
*Wilcoxon rank sum test; †χ2 test; ‡Fisher's exact test.
Comparison of VAS pain scores
| Comparisons | PB group (n=48) | LE group (n=48) | p-value* |
|---|---|---|---|
| VAS pain score (median) | 3.4 | 3.4 | 0.820 |
LE group, round loop electrode group; PB group, punch biopsy forceps group; VAS, visual analog scale.
*Wilcoxon rank sum test.